O slideshow foi denunciado.
Innovation & Simplicity    for our clients       success!
Our Heritage          Established          since 1984                                     We assist                       ...
MEDI-PRAGMA CAPABILITIES                Coverage of both                                                                Av...
METHODOLOGIES FOR DATA COLLECTION      Bespoke – Tailored - Flexible             DATA COLLECTION IS CARRIED               ...
MEDI-PRAGMA VALUE FOR OUR CLIENTS
OUR OFFERINGS FOR PHARMAKnowledge               Commercial Research               Effectiveness Strategy       Consultant ...
OUR OFFERINGS FOR PHARMAMARKET POTENTIAL/DEFINITION     MARKETING MIX OPTIMIZATION                 RELATIONSHIP     PRODUC...
THERE YOU HAVE IT: FOURTEEN MARKET RESEARCH                                                      OPTIONS THAT ARE NOT “TRA...
MAIN CLIENTS                                              Dermatology                                                 3%  ...
N° OF INT’S STUDIES                              OVER THE PAST7060                           66504030                   53...
COUNTRIES INVOLVED           7,0%   10,0%                   25,0%                           UK                           S...
Challenge your agencies   Knowledge Research Strategy                          Commercial Effectiveness                   ...
Medi Pragma  2012
Próximos SlideShares
Carregando em…5
×

Medi Pragma 2012

835 visualizações

Publicada em

  • Seja o primeiro a comentar

  • Seja a primeira pessoa a gostar disto

Medi Pragma 2012

  1. 1. Innovation & Simplicity for our clients success!
  2. 2. Our Heritage Established since 1984 We assist  Business Intelligence to achieve a deep knowledge of the Market, Customer and Brand.Over  Commercial Operation to maximise performance and the return on their investments.120 projects per year   Innovators to create more successful propositions. CEO’s to grow profits through customer- centricity. 40% International Rome Some HQ Credentials Special Milan & P&G Relationship others 18 Pfizer countries Forest through our Daiichi-Sankyo MEDINET Johnson & Johnson Univ. “La Sapienza” Novo Nordisk NOMOS network € 151.000 average Eurogroup SIIA, SID, SIP, sales per person/year AIOM, etc...
  3. 3. MEDI-PRAGMA CAPABILITIES Coverage of both Availability of applied qual and quant statistical capability research Consulting attitude Strong project management …and also knowledge on the therapeutic areaValerio Carboniero: Offering for Metabolic & CV disease, device, Francesca Venturi Visconti: Offering for Vaccines, Antibiotics,customer satisfactions & brand tracking Parallel Imports, value proposition & communication testQuantitative Research Director Qualitative Research ManagerVincenzo Falco: Offering for Oncology, Hematology, Orphan Drugs & Bruno Sfogliarini: Offering for Forecasting, Marketing Mix,Market Access Segmentation & Targeting, Market PotentialR&D Manager Medi-Pragma Nord DirectorLucio Carsana: Offering for SFE, Selling skills, Field manager coach Gokay Ustun: Offering for Transplant, Hemophilia & RheumatoidBusiness Development arthritisAlfonso Martuscelli: Offering for Vaccines, Mature Products, Business DevelopmentHemophilia & CNS Emanuele Corsaro: Offering for Pharmacy, Wholesalers & OTCField Manager International Account Manager
  4. 4. METHODOLOGIES FOR DATA COLLECTION Bespoke – Tailored - Flexible DATA COLLECTION IS CARRIED OUT EXCLUSIVELY BY ESPECIALLY TRAINED AND BRIEFED QUALIFIED PERSONNEL (MEDICAL DOCTORS, BIOLOGISTS, PSYCHOLOGISTS, PROFESSIONAL INTERVIEWERS)
  5. 5. MEDI-PRAGMA VALUE FOR OUR CLIENTS
  6. 6. OUR OFFERINGS FOR PHARMAKnowledge Commercial Research Effectiveness Strategy Consultant Business Solution
  7. 7. OUR OFFERINGS FOR PHARMAMARKET POTENTIAL/DEFINITION MARKETING MIX OPTIMIZATION RELATIONSHIP PRODUCTS/BRAND LCM SEGMENTATION & TARGETING INTELLIGENCE PHARMA SOLUTION CUSTOMER POTENTIAL MARKET ACCESS IN BOUND & OUT BOUND PROJECT CUSTOMER/ PRODUCT VALUE PROPOSITION BUSINESS MODEL DRUGS DEVELOPMENT VALUE CHAIN COMPANY/BRANDIDENTITY/COMMUNICATION/IMAGE/ CALL QUALITY SALES CAMPAIGN PLANNING REPUTATION & DEPLOYMENT MKT/COMPETITIVE INTELLIGENCE & GAP ANALYSIS NON PERSONAL PROMOTION
  8. 8. THERE YOU HAVE IT: FOURTEEN MARKET RESEARCH OPTIONS THAT ARE NOT “TRADITIONAL” METHODS Fourteenisalot,sotocategorize themethods, usethetable below.Thecategories areself-explanatory, andareausefulwaytodrawdistinctions.METODOLOGIES WHEN USE MEDI-PRAGMA ANALYTICS TOOLECONOMETRICS ROI, KPI, PERFORMANCE ASSESTMENT, GAP ANALYSIS, MARKETING MIX ALLOCATION, ROMI, SHIFT SHARE, EVENT IMPACT, SoV, SELETRACK, TRAXER MS, PATIENTS INCIDENCE & PREVALENCE, SCENARIOUSINTANGIBLE METRICS ROI, BRAND VALUE & POSITIONING, KPI, VALUE PROPOSITION, IMPACT OF REPUTACTION,IDEA, SoV, SELETRACK, TRAXER, KANO MODEL, FI.DO INNOVATION, GAP ANALYSIS, MARKETING MIX ALLOCATION, PERFORMANCE ASSESTMENT, AWARENESSEMOTIOMETRICS BRAND VALUE, POSITIONING, EFFECTIVENESS OF MESSAGES, VALUE PROPOSITION, EXCELLENCE CIRCLE, EMOTIONAL SELLING, SOCIAL AWARENESS, KANO MODEL, COMMUNICATION CHANNEL SET UP, CUSTOMER INFLUENCE T.O.T.E. , TRAXERNEUROMARKETING BRAND VALUE, POSITIONING, EFFECTIVENESS OF MESSAGES, VALUE PROPOSITION, EYE TRACKING, FACIAL CODING COMMUNICATION CHANNEL SET UP, CUSTOMER INFLUENCEENGAGEMENT BRAND PIRAMID: AWARENESS, ASSOCIATION, FAMILIARITY, ATTITUDES, IDENTITY, STRUCTURAL EQUATION MODEL, AMOS, TRAXER PERSONALITY, IMAGE, PREFERENCE, POSITION, EQUITY-CONCEPT TESTINGEXPERT INTERVIEW VALUE PROPOSITION, SCENARIOUS, COMMUNICATION CHANNEL SET UP, LATERAL KOLABORATION, STAKHOLABORATION, THINKING, NEW NEEDS DESCOVERY, GAP ANALYSIS, DEFIND BARRIERS TO ACCESS LADDERING, SIX HATS FG, ANALYTIC HIERARCHY PROCESSETNOGRAPHIC SOURCE OF BUSINESS, SWITCHES DINAMICS, PATIENTS LIFE STORY, COMPLIANCE VIDEO LAB, PHARMA MISTERY SHOPPING, VESPRO, “24: Twenty for you”DIGITAL MARKETING SOCIAL MEDIA, NON PERSONAL PROMOTION, E-DETAILING, E-MARKETING, E-REPS, BUZZ SENTIMENT, EYE TRACKING, WEB ANALYTICS, E-BIZZ SATISFACTION, REPRESEARCH VIRAL MARKETING, AWARENESS EQUIVALENT MODELFORECASTING SCENARIOUS, RISK AND UNCERTAINTY, DECISION ANALYSIS FORECASTING TOOL, SIMULATION TECHNIQUES, WATERFALL DIAGRAMM, …TEXT ANALITICS VALUE PROPOSITION, SCENARIOUS, COMMUNICATION CHANNEL SET UP, LATERAL Nvivo9, LEXICON, WORDERING ANALYTICS THINKING, NEW NEEDS DESCOVERY, AWARENESSMROCS VALUE PROPOSITION, SCENARIOUS, COMMUNICATION CHANNEL SET UP, LATERAL DELPHI ONLINE, KOLMUNNITY, ANALYTIC HIERARCHY PROCESS THINKING, NEW NEEDS DESCOVERYNEW CUSTOMER PROFILING & COSTUMER SEGMENTATION & TARGETING BASED ON VALUE PROPOSITION AND/OR CLUSTER ANALYSIS, MANOVA, DISCRIMINANT ANALYSIS, CONJOINT ANALYSIS,MAPPING VOLUMETRICS ATTITUDE, DEFIND BARRIERS TO ACCESS STAKEHOLDERS NETWORKING & INFLUENCE, I-PHARM DATA BASE, CORRESPONDENCE MAPPING ANALYSIS, MULTIDIMENSIONAL SCALING (MDS)HOLISTIC BRAND VALUE, POSITIONING, EFFECTIVENESS OF MESSAGES, VALUE PROPOSITION, HALL TEST, STORY BOARD & SELLING, HOLLYWOOD, SIX HATS FG, TERRITORY FG, COMMUNICATION CHANNEL SET UP, DEFIND BARRIERS TO ACCESS, AWARENESS, KANO MODEL, SELETRACK, TRAXER LOYALTY, CONCEPT TESTTRANSFORMATIONAL TO EVELUATE INTERNAL STAFF, DESCOVER AREA OF IMPROVING, BUILD A GOOD ICQ, CMC, STRACOM, ASSERTIVITY, CHANGE MANAGEMENT, REP’S EMPATYLEARNING HUMAN ENVIRONMENT, ANALYZE MANAGEMENT SYSTEMS AND LEADERSHIP STYLE
  9. 9. MAIN CLIENTS Dermatology 3% Sales Force Effectiveness Others 17% 10% Cardiovascular Consumer 20% 11%Rheumatology 5% Gastrointestinal CNS/Psychiatry 4% 10% Oncology Diabetes 10% Medical Device 5% 5%
  10. 10. N° OF INT’S STUDIES OVER THE PAST7060 66504030 5320 31 45100 2007 2008 2009 2010
  11. 11. COUNTRIES INVOLVED 7,0% 10,0% 25,0% UK SPAIN GERMANY20,0% FRANCE 18,0% USA OTHER 20,0%
  12. 12. Challenge your agencies Knowledge Research Strategy Commercial Effectiveness Intelligence Business Solution

×